These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 2130713

  • 1. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P, Paul KD, Wehner J.
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [Abstract] [Full Text] [Related]

  • 2. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
    Steinkamp G.
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibiotic use in cystic fibrosis.
    Eisenberg JD.
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF Study Consortium (SCFSC).
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [Abstract] [Full Text] [Related]

  • 7. [Cystic fibrosis: current therapy. Antibiotics].
    Tamm M, Héritier F, Rappaz I, Schaad UB.
    Schweiz Med Wochenschr Suppl; 2000 Mar; 122():33S-37S. PubMed ID: 12536469
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics.
    Ballmann M, Smyth A, Geller DE.
    Respir Med; 2011 Dec; 105 Suppl 2():S2-8. PubMed ID: 22208546
    [Abstract] [Full Text] [Related]

  • 9. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN, Ratjen F.
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A more objective approach to the evaluation of antimicrobial therapy in cystic fibrosis.
    Valletta EA, Rigo A, Bonazzi L, Zanolla L, Mastella G.
    Acta Univ Carol Med (Praha); 1990 Oct; 36(1-4):44-5. PubMed ID: 2130717
    [Abstract] [Full Text] [Related]

  • 13. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Gappa M, Steinkamp G, Tümmler B, von der Hardt H.
    Scand J Gastroenterol Suppl; 1988 Oct; 143():74-6. PubMed ID: 3164515
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection].
    Mordasini C, Aebischer CC, Schoch OD.
    Schweiz Med Wochenschr; 1997 May 24; 127(21):905-10. PubMed ID: 9289818
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.
    Antoniu S.
    Expert Rev Anti Infect Ther; 2015 Jul 24; 13(7):897-905. PubMed ID: 25921312
    [Abstract] [Full Text] [Related]

  • 20. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
    Vávrová V, Lochmann O, Suková B, Copová M, Zapletal A, Absolonová V, Houstĕk J.
    Cesk Pediatr; 1986 Oct 24; 41(10):605-7. PubMed ID: 3502950
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.